Increases 2024 Treatment Site Activation Guidance to 20 Sites QUEENSBURY, N.Y., March 26, 2024 /PRNewswire/ — Delcath Systems, Inc. (Nasdaq: DCTH) (“Delcath” or the “Company”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver,…